Related Experiment Video
Updated: Aug 13, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated
Wei Yang1, Yan Chen, Yong Zhang
1National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 5 Dong Dan San Tiao, Beijing 100-005, P.R. China.
Abstract:
The cytokines of transforming growth factor beta (TGF-beta) and its superfamily members are potent regulators of tumorigenesis and multiple cellular events. Myostatin is a member of TGF-beta superfamily and plays a negative role in the control of cell proliferation and differentiation. We now show that myostatin rapidly activated the extracellular signal-regulated kinase 1/2 (Erk1/2) cascade in C2C12 myoblasts. A more remarkable Erk1/2 activation stimulated by myostatin was observed in differentiating cells than proliferating cells. The results also showed that Ras was the upstream regulator and participated in myostatin-induced Erk1/2 activation because the expression of a dominant-negative Ras prevented myostatin-mediated inhibition of Erk1/2 activation and proliferation. Importantly, the myostatin-suppressed myotube fusion and differentiation marker gene expression were attenuated by blockade of Erk1/2 mitogen-activated protein kinase (MAPK) pathway through pretreatment with MAPK/Erk kinase 1 (MEK1) inhibitor PD98059, indicating that myostatin-stimulated activation of Erk1/2 negatively regulates myogenic differentiation. Activin receptor type IIb (ActRIIb) was previously suggested as the only type II membrane receptor triggering myostatin signaling. In this study, by using synthesized small interfering RNAs and dominant-negative ActRIIb, we show that myostatin failed to stimulate Erk1/2 phosphorylation and could not inhibit myoblast differentiation in ActRIIb-knockdown C2C12 cells, indicating that ActRIIb was required for myostatin-stimulated differentiation suppression. Altogether, our findings in this report provide the first evidence to reveal functional role of the Erk1/2 MAPK pathway in myostatin action as a negative regulator of muscle cell growth.
Insights
Myostatin negatively regulates muscle cell growth by activating the Erk1/2 MAPK pathway. This pathway, involving Ras and ActRIIb, is crucial for myostatin
Area of Science:
- Molecular Biology
- Cell Signaling
- Muscle Development
Background:
- Transforming growth factor beta (TGF-beta) superfamily cytokines regulate tumorigenesis and cellular events.
- Myostatin, a TGF-beta superfamily member, inhibits cell proliferation and differentiation.
Purpose of the Study:
- To investigate the role of the extracellular signal-regulated kinase 1/2 (Erk1/2) mitogen-activated protein kinase (MAPK) pathway in myostatin signaling.
- To elucidate the upstream regulators and downstream effects of myostatin-induced Erk1/2 activation in muscle cells.
Main Methods:
- Utilized C2C12 myoblasts to study myostatin's effects on Erk1/2 activation and myogenic differentiation.
- Employed dominant-negative Ras and MEK1 inhibitor (PD98059) to assess pathway involvement.
- Used small interfering RNAs (siRNAs) and dominant-negative Activin receptor type IIb (ActRIIb) to investigate receptor function.
Main Results:
- Myostatin rapidly activated the Erk1/2 cascade in C2C12 myoblasts, with greater activation in differentiating cells.
- Ras was identified as an upstream regulator of myostatin-induced Erk1/2 activation and proliferation inhibition.
- Myostatin-suppressed myotube fusion and differentiation were rescued by blocking the Erk1/2 MAPK pathway.
- ActRIIb knockdown prevented myostatin-induced Erk1/2 phosphorylation and differentiation suppression, confirming its necessity.
Conclusions:
- The Erk1/2 MAPK pathway is a key mediator of myostatin's negative regulatory effects on muscle cell growth and differentiation.
- ActRIIb is essential for myostatin signaling, including Erk1/2 activation and inhibition of myogenic differentiation.
More Related Videos
10:45Isolation of Human Myoblasts, Assessment of Myogenic Differentiation, and Store-operated Calcium Entry Measurement
Published on: July 26, 2017
07:26Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
Published on: April 1, 2022
Related Concept Videos
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...